GBBWRPM
PRQR icon

Genovese Burford & Brothers Wealth & Retirement Plan Management’s ProQR Therapeutics PRQR Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-7,500
Closed -$55K – 297
2018
Q2 		$55K Hold
7,500
– – 0.02% 167
2018
Q1 		$23K Hold
7,500
– – 0.01% 236
2017
Q4 		$24K Buy
+7,500
New +$26.9K 0.06% 132

Other funds holding PRQR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's PRQR Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of ProQR Therapeutics (PRQR) in Q3 2018, closing a stake of 7,500 shares — an estimated $55K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in PRQR in Q4 2017 and held it in 3 quarters. The position peaked at $55K in Q2 2018. 34 funds tracked by Wall St. Rank hold PRQR as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining ProQR Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 7,500 ProQR Therapeutics shares in Q3 2018, an estimated $55K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in ProQR Therapeutics in Q4 2017 and held it in 3 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's ProQR Therapeutics position peaked at $55K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.